Haleon is one of the largest consumer health companies in the world... Show more
The Moving Average Convergence Divergence (MACD) for HLN turned positive on April 16, 2025. Looking at past instances where HLN's MACD turned positive, the stock continued to rise in of 21 cases over the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HLN's RSI Oscillator exited the oversold zone, of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on HLN as a result. In of 49 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
HLN moved above its 50-day moving average on April 11, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HLN advanced for three days, in of 167 cases, the price rose further within the following month. The odds of a continued upward trend are .
HLN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The 10-day moving average for HLN crossed bearishly below the 50-day moving average on April 09, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HLN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for HLN entered a downward trend on April 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.817) is normal, around the industry mean (61.171). P/E Ratio (29.230) is within average values for comparable stocks, (90.174). Projected Growth (PEG Ratio) (1.706) is also within normal values, averaging (2.987). Dividend Yield (0.018) settles around the average of (0.122) among similar stocks. P/S Ratio (2.707) is also within normal values, averaging (20.123).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HLN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.
Ticker / NAME | Correlation To HLN | 1D Price Change % | ||
---|---|---|---|---|
HLN | 100% | +2.55% | ||
HLNCF - HLN | 49% Loosely correlated | +5.65% | ||
TAK - HLN | 31% Poorly correlated | +2.68% | ||
BHC - HLN | 25% Poorly correlated | +9.96% | ||
HCM - HLN | 25% Poorly correlated | +12.31% | ||
VTRS - HLN | 25% Poorly correlated | +1.59% | ||
More |